WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 4 fonti

U.S. Obesity Rate Drops As GLP-1 Usage Grows

A new Gallup poll found about 11% of Americans were taking a GLP-1 medication for weight loss.

Raccontata danbcnews.comforbes.commedpagetoday.comgizmodo.com

Confronto fonti

4 prospettive sulla stessa storia
AI · summaries
forbes.comStai leggendo1 g fa

U.S. Obesity Rate Drops As GLP-1 Usage Grows

A new Gallup poll found about 11% of Americans were taking a GLP-1 medication for weight loss.

originale
gizmodo.com2 h fa

11% of Americans Are Currently Taking a GLP-1 Weight Loss Drug Like Wegovy

15% of Americans have ever taken the drugs, up from 6% in 2024.

Leggi questa versione → originale

Timeline cronologica

  1. lunedì 6 luglio 2026·nbcnews.com

    New research aims to get closer to settling the fierce debate over what GLP-1s are worth

    As a new Medicare program expands access to weight-loss drugs, high costs leave many who could benefit from them shut out.

  2. martedì 7 luglio 2026·forbes.com

    U.S. Obesity Rate Drops As GLP-1 Usage Grows

    A new Gallup poll found about 11% of Americans were taking a GLP-1 medication for weight loss.

medpagetoday.com13 h fa

Record High GLP-1 Use; Intense Interval Exercise; Endometriosis and Androgens

News and commentary from the endocrinology world

Leggi questa versione → originale
nbcnews.com1 g fa

New research aims to get closer to settling the fierce debate over what GLP-1s are worth

As a new Medicare program expands access to weight-loss drugs, high costs leave many who could benefit from them shut out.

Leggi questa versione → originale
martedì 7 luglio 2026·medpagetoday.com

Record High GLP-1 Use; Intense Interval Exercise; Endometriosis and Androgens

News and commentary from the endocrinology world

  • mercoledì 8 luglio 2026·gizmodo.com

    11% of Americans Are Currently Taking a GLP-1 Weight Loss Drug Like Wegovy

    15% of Americans have ever taken the drugs, up from 6% in 2024.